Simplex Trading, LLC Galectin Therapeutics Inc Transaction History

Simplex Trading, LLC

$2.98 Billion
Q2 2024

A detailed history of Simplex Trading, LLC transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 11,354 shares of GALT stock, worth $30,088. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,354

Previous 7,877 44.14%

Holding current value

$30,088

Previous $18,000 38.89%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$2.13 - $4.2 $7,406 - $14,603	3,477 Added 44.14%	11,354 $25,000
Q1 2024 Apr 25, 2024	BUY	$1.6 - $2.44 $1,467 - $2,237	917 Added 13.18%	7,877 $18,000
Q4 2023 Feb 02, 2024	SELL	$1.6 - $2.18 $5,979 - $8,146	-3,737 Reduced 34.94%	6,960 $11,000
Q3 2023 Nov 01, 2023	BUY	$1.38 - $1.97 $2,598 - $3,709	1,883 Added 21.36%	10,697 $20,000
Q2 2023 Aug 04, 2023	BUY	$1.32 - $2.08 $1,078 - $1,699	817 Added 10.22%	8,814 $12,000
Q1 2023 Apr 27, 2023	SELL	$1.1 - $2.4 $12,898 - $28,142	-11,726 Reduced 59.45%	7,997 $16,000
Q4 2022 Feb 02, 2023	BUY	$1.03 - $1.66 $9,571 - $15,426	9,293 Added 89.1%	19,723 $22,000
Q3 2022 Nov 04, 2022	SELL	$1.31 - $2.48 $22,847 - $43,253	-17,441 Reduced 62.58%	10,430 $17,000
Q2 2022 Aug 03, 2022	BUY	$1.19 - $1.74 $17,766 - $25,978	14,930 Added 115.37%	27,871 $36,000
Q1 2022 May 02, 2022	BUY	$1.61 - $2.31 $13,902 - $19,946	8,635 Added 200.53%	12,941 $20,000
Q4 2021 Feb 23, 2022	BUY	$2.07 - $3.8 $8,913 - $16,362	4,306 New	4,306 $8,000
Q2 2021 Aug 12, 2021	SELL	$2.07 - $5.1 $8,093 - $19,941	-3,910 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$1.96 - $2.57 $7,547 - $9,897	3,851 Added 6527.12%	3,910 $8,000
Q4 2020 Feb 02, 2021	BUY	$2.24 - $2.87 $132 - $169	59 New	59 $0
Q2 2020 Jul 13, 2020	SELL	$1.66 - $3.15 $2,895 - $5,493	-1,744 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$1.51 - $3.0 $2,633 - $5,232	1,744 New	1,744 $3,000
Q3 2019 Oct 15, 2019	SELL	$3.0 - $4.05 $2,958 - $3,993	-986 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$3.61 - $5.0 $3,559 - $4,930	986 New	986 $4,000
Q1 2019 Apr 18, 2019	SELL	$3.86 - $6.02 $29,826 - $46,516	-7,727 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$3.43 - $5.74 $14,433 - $24,153	4,208 Added 119.58%	7,727 $26,000
Q3 2018 Oct 23, 2018	BUY	$3.68 - $6.93 $12,949 - $24,386	3,519 New	3,519 $21,000
Q2 2018 Jul 30, 2018	SELL	$3.16 - $9.16 $4,155 - $12,045	-1,315 Closed	0 $0
Q1 2018 Apr 26, 2018	SELL	$3.78 - $5.97 $13,967 - $22,059	-3,695 Reduced 73.75%	1,315 $6,000
Q4 2017 Jan 10, 2018	SELL	$1.54 - $3.34 $36,462 - $79,081	-23,677 Reduced 82.54%	5,010 $16,000
Q3 2017 Oct 25, 2017	BUY	$1.67 - $2.3 $47,907 - $65,980	28,687	28,687 $61,000

Others Institutions Holding GALT

# of Institutions

Shares Held

9.35M

Call Options Held

982K

Put Options Held

2.7K

View Full List

About GALECTIN THERAPEUTICS INC

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $157M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

More about GALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Galectin Therapeutics Inc Transaction History